| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |